PR1 Vaccination in Myelodysplastic Syndrome (MDS)

Clinical trial NCT00893997 · TERMINATED

Trial details

NCT number: NCT00893997
Sponsor: M.D. Anderson Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia Myelodysplastic Syndrome

Start date: 2006-07-01
Primary completion: 2009-03-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.